Point72 Hong Kong’s iRadimed IRMD Stock Holding History

Point72 Hong Kong’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40	Closed	-$2K	–	2082
2021 Q4	$2K	Buy	+40	New	+$1.61K	﹤0.01%	1777

Other funds holding IRMD

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RCG

Resource Consulting Group Orlando, Florida $584M AUM 15.38% 1-Year Est. Return

Point72 Hong Kong's IRMD Position: Q1 2022 in Review

Point72 Hong Kong sold out of iRadimed (IRMD) in Q1 2022, closing a stake of 40 shares — an estimated $2K sold.

Point72 Hong Kong first reported a position in IRMD in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 103 funds tracked by Wall St. Rank hold IRMD as of Q1 2022.

Point72 Hong Kong reported no remaining iRadimed position as of Q1 2022 after selling out during the quarter.
Point72 Hong Kong sold 40 iRadimed shares in Q1 2022, an estimated $2K.
Point72 Hong Kong first reported a position in iRadimed in Q4 2021 and held it in 1 quarter.
Point72 Hong Kong's iRadimed position peaked at $2K in Q4 2021.
103 funds tracked by Wall St. Rank held iRadimed as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.